Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6.93% is 72% above its 5-year average of -24.98%, near the high end of its 5-year range (-203.85%–45.29%).
6.19% below its 12-month average of -6.53%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1.22%.
NET PROFIT MARGIN
-6.93%
NET PROFIT MARGIN AVG TTM
-6.53%
NET PROFIT MARGIN AVG 3Y
5.74%
NET PROFIT MARGIN AVG 5Y
-24.98%
NET PROFIT MARGIN AVG 10Y
-64.58%
NET PROFIT MARGIN AVG 15Y
-65.73%
NET PROFIT MARGIN AVG 20Y
-92.86%
CURRENT VS TTM AVG
-6.19%
CURRENT VS 3Y AVG
-220.81%
CURRENT VS 5Y AVG
+72.26%
CURRENT VS 10Y AVG
+89.27%
CURRENT VS 15Y AVG
+89.46%
CURRENT VS 20Y AVG
+92.54%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-2565.38%
vs the sector median at left
Sarepta Therapeutics, Inc.
Market Cap
$1.83B
Net Profit Margin
-6.93%
TTM Avg
-6.53%
3Y Avg
5.74%
5Y Avg
-24.98%
Market Cap
$1.82B
Net Profit Margin
25.02%
TTM Avg
21.58%
3Y Avg
17.87%
5Y Avg
17.55%
Market Cap
$1.81B
Net Profit Margin
-155.59%
TTM Avg
-141.87%
3Y Avg
-98.38%
5Y Avg
-69.99%
Market Cap
$1.85B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$1.85B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.80B
Net Profit Margin
-59.87%
TTM Avg
5.85%
3Y Avg
-31.86%
5Y Avg
-479.70%
Market Cap
$1.80B
Net Profit Margin
-636.99%
TTM Avg
-743.17%
3Y Avg
-743.17%
5Y Avg
-743.17%
Market Cap
$1.84B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.78B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | $1.83B | -6.93% | -6.53% | 5.74% | -24.98% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 25.02% | 21.58% | 17.87% | 17.55% |
| Xencor, Inc. (XNCR)vs › | $1.81B | -155.59% | -141.87% | -98.38% | -69.99% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 1.05% | 1.42% | 2.79% | 2.28% |
| Novavax, Inc. (NVAX)vs › | $1.80B | -59.87% | 5.85% | -31.86% | -479.70% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.80B | -636.99% | -743.17% | -743.17% | -743.17% |
| Azenta, Inc. (AZTA)vs › | $1.84B | -20.02% | -19.08% | -29.38% | -13.21% |
| Absci Corporation (ABSI)vs › | $1.78B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Novocure Ltd (NVCR)vs › | $1.78B | -21.25% | -24.32% | -26.63% | -18.90% |
Operating Margin
-29.9%
Net Profit Margin
-6.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1.22% |
| 2026-03-31 | 45.29% |
| 2025-12-31 | -63.86% |
| 2025-09-30 | -45.06% |
| 2025-06-30 | 32.22% |
| 2025-03-31 | -60.08% |
| 2024-12-31 | 24.16% |
| 2024-09-30 | 7.19% |
| 2024-06-30 | 1.78% |
| 2024-03-31 | 8.74% |
| 2023-12-31 | 11.51% |
| 2023-09-30 | -12.34% |
| 2023-06-30 | -9.16% |
| 2023-03-31 | -203.85% |
| 2022-12-31 | -42.27% |
| 2022-09-30 | -111.93% |
| 2022-06-30 | -99.14% |
| 2022-03-31 | -49.82% |
| 2021-12-31 | -60.55% |
| 2021-09-30 | -25.42% |
| 2021-06-30 | -49.61% |
| 2021-03-31 | -113.83% |
| 2020-12-31 | -130.44% |
| 2020-09-30 | -136.53% |
| 2020-06-30 | -109.80% |
| 2020-03-31 | -15.39% |
| 2019-12-31 | -235.44% |
| 2019-09-30 | -127.55% |
| 2019-06-30 | -291.97% |
| 2019-03-31 | -88.08% |
| 2018-12-31 | -166.91% |
| 2018-09-30 | -97.33% |
| 2018-06-30 | -148.60% |
| 2018-03-31 | -54.74% |
| 2017-12-31 | -41.90% |
| 2017-09-30 | -103.87% |
| 2017-06-30 | -180.07% |
| 2017-03-31 | 514.56% |
| 2016-12-31 | -1631.65% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | -5162.09% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | -164503.70% |
| 2014-09-30 | -2759.77% |
| 2014-06-30 | -1311.42% |
| 2014-03-31 | -464.41% |
| 2013-12-31 | -335.87% |
| 2013-09-30 | -1008.40% |
| 2013-06-30 | -645.58% |
| 2013-03-31 | -940.63% |
| 2012-12-31 | -846.06% |
| 2012-09-30 | -654.26% |
| 2012-06-30 | 71.72% |
| 2012-03-31 | -157.90% |
| 2011-12-31 | -10.38% |
| 2011-09-30 | -53.43% |
| 2011-06-30 | 11.04% |
| 2011-03-31 | 12.82% |
| 2010-12-31 | -49.26% |
| 2010-09-30 | -83.81% |
| 2010-06-30 | -416.71% |
| 2010-03-31 | -48.46% |
| 2009-12-31 | 68.57% |
| 2009-09-30 | -127.42% |
| 2009-06-30 | -667.84% |
| 2009-03-31 | -29.43% |
| 2008-12-31 | -20.81% |
| 2008-09-30 | -116.95% |
| 2008-06-30 | -35.13% |
| 2008-03-31 | -266.94% |
| 2007-12-31 | -79.58% |
| 2007-09-30 | -241.63% |
| 2007-06-30 | -363.04% |
| 2007-03-31 | -1813.85% |
| 2006-12-31 | -47543.74% |
| 2006-09-30 | -51166.96% |
| 2006-06-30 | -37191.66% |
| 2006-03-31 | -13736.92% |
| 2005-12-31 | -321.11% |
| 2005-09-30 | -51.57% |
| 2005-06-30 | -12545.82% |
| 2005-03-31 | -12168.48% |
| 2004-12-31 | -1747.36% |
| 2004-09-30 | -55807.74% |
| 2004-06-30 | -19707.10% |
| 2004-03-31 | -7574.09% |
| 2003-12-31 | -2290.43% |
| 2003-09-30 | -1111.05% |
| 2003-06-30 | -2153.76% |
| 2003-03-31 | -1325.52% |
| 2002-12-31 | -2360.34% |
| 2002-09-30 | -3036.83% |
